Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epistatus 7.5mg/0.75ml oromucosal soln pf oral syringes
0408020V0BCADAW
|
Epistatus | Midazolam maleate | Central Nervous System | 24 |
|
Morphine 100mg modified-release granules sachets sugar free
0407020Q0AADDDD
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 24 |
|
NiQuitin 4mg lozenges original menthol mint
0410020B0BDAHAZ
|
NiQuitin | Nicotine | Central Nervous System | 24 |
|
Pethidine 50mg capsules
0407020V0AABFBF
|
Pethidine hydrochloride | Pethidine hydrochloride | Central Nervous System | 24 |
|
Selincro 18mg tablets
0410010D0BBAAAA
|
Selincro | Nalmefene | Central Nervous System | 24 |
|
Strattera 100mg capsules
0404000S0BBAGAH
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 24 |
|
Trihexyphenidyl 2mg/5ml oral solution
0409020C0AAASAS
|
Trihexyphenidyl hydrochloride | Trihexyphenidyl hydrochloride | Central Nervous System | 24 |
|
Zebinix 50mg/1ml oral suspension
0408010AIBBACAC
|
Zebinix | Eslicarbazepine acetate | Central Nervous System | 24 |
|
Abilify 10mg orodispersible tablets
0402010ADBBAEAE
|
Abilify | Aripiprazole | Central Nervous System | 23 |
|
Abtard 15mg modified-release tablets
0407020ADBMACAS
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 23 |
|
Almogran 12.5mg tablets
0407041B0BBAAAA
|
Almogran | Almotriptan | Central Nervous System | 23 |
|
PecFent 400micrograms/dose nasal spray
0407020A0BPABBP
|
PecFent | Fentanyl | Central Nervous System | 23 |
|
Stesolid 10mg rectal tube
0401020K0BDACAE
|
Stesolid | Diazepam | Central Nervous System | 23 |
|
Buprenorphine 64mg/0.18ml prolonged-release inj pfs
0410030A0AAASAS
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 22 |
|
Carbamazepine 125mg suppositories
0408010C0AAAUAU
|
Carbamazepine | Carbamazepine | Central Nervous System | 22 |
|
Epistatus 5mg/0.5ml oromucosal soln pre-filled oral syringes
0408020V0BCACAV
|
Epistatus | Midazolam maleate | Central Nervous System | 22 |
|
Olanzapine embonate 300mg inj vials
0402020ACAAABAB
|
Olanzapine embonate | Olanzapine embonate | Central Nervous System | 22 |
|
Paracetamol 500mg/5ml oral liquid
0407010H0AACPCP
|
Paracetamol | Paracetamol | Central Nervous System | 22 |
|
Relpax 20mg tablets
0407041AABBAAAA
|
Relpax | Eletriptan | Central Nervous System | 22 |
|
Secobarbital sodium 50mg capsules
0401030T0AAAAAA
|
Secobarb sodium | Secobarbital sodium | Central Nervous System | 22 |
|
Zamadol 24hr 200mg modified-release tablets
040702040BDAIAE
|
Zamadol | Tramadol hydrochloride | Central Nervous System | 22 |
|
Abilify 15mg orodispersible tablets
0402010ADBBAFAF
|
Abilify | Aripiprazole | Central Nervous System | 21 |
|
Atrolak XL 200mg tablets
0402010ABBGABAW
|
Atrolak XL | Quetiapine | Central Nervous System | 21 |
|
Chloral hydrate 250mg suppositories
0401010B0AAAJAJ
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 21 |
|
Dilantin Infatabs 50mg chewable tablets
0408010Z0BCAAAC
|
Dilantin | Phenytoin | Central Nervous System | 21 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.